OMED

OncoMed Pharmaceuticals, Inc.
OMED

Overview Fund Activity
Delisted

OMED was delisted on the 22nd of April, 2019.

Back to rankings

53 hedge funds and large institutions have $66.3M invested in OncoMed Pharmaceuticals, Inc. in 2013 Q3 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Holders
53
Holders Change
+53
Holders Change %
–
% of All Funds
1.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
53
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SAM
1
Sectoral Asset Management
Quebec, Canada
$16.2M
2
BI
2
BVF Inc
California
$6M
3
CII
3
CR Intrinsic Investors
Connecticut
$4.14M
4
Alyeska Investment Group
4
Alyeska Investment Group
Illinois
$4.12M
5
Primecap Management
5
Primecap Management
California
$3.75M

Top Sellers

No sellers this quarter
Name Market Value Shares Shares
Change 		Shares
Change %
TRCT
51
Tower Research Capital (TRC)
New York
$3K 200 +200 New
AllianceBernstein
52
AllianceBernstein
Tennessee
$1K 73 +73 New
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3 177 +177 New
1 2
3